Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up

Lung Cancer

Volumn 83, Issue 1, 2014, Pages 78-82

  Minatel, Emilio ^a   Trovo, Marco ^a   Polesel, Jerry ^a   Baresic, Tania ^a   Bearz, Alessandra ^a   Franchin, Giovanni ^a   Gobitti, Carlo ^a   Rumeileh, Imad Abu ^a   Drigo, Annalisa ^a   Fontana, Paolo ^b   Pagan, Vittore ^a   Trovo, Mauro G ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Division of Nephrology   (Italy)

Author keywords

IMRT; Intensity modulated radiation therapy; Malignant pleural mesothelioma; Pleurectomy decortication; Pneumonitis; Tomotherapy

Indexed keywords

CISPLATIN; PEMETREXED;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KAPLAN MEIER METHOD; LONG TERM SURVIVAL; MALE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PLEURECTOMY; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADICAL PLEURECTOMY DECORTICATION; TOMOTHERAPY; VERY ELDERLY;

IMRT; INTENSITY MODULATED RADIATION THERAPY; MALIGNANT PLEURAL MESOTHELIOMA; PLEURECTOMY/DECORTICATION; PNEUMONITIS; TOMOTHERAPY;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURA; PLEURAL EFFUSION, MALIGNANT; THORACIC SURGICAL PROCEDURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891741016     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.10.013     Document Type: Article

References (18)

1. Peto J., Decarli A., La Vecchia C., Levi F., Negri E. The European mesothelioma epidemic. Br J Cancer 1999, 79:666-672.
2. Sugarbaker D.J., Flores R.M., Jacklitsch M. Resection margins, extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999, 117:54-63.
3. Stahel R.A., Weder W., Lievens Y., Felip E. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21:126-128.
4. Hiddinga B.I., van Meerbeeck J.P. Surgery in mesothelioma - where do we go after MARSα. J Thorac Oncol 2013, 8:525-529.
5. Treasure T., Lang-Lazdunski L., Waller D. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomized feasibility study. Lancet Oncol 2011, 12(8):763-772.
6. Sugarbaker D.J., Wolf A.S. Surgery for malignant pleural mesothelioma. Expert Rev Respir Med 2010, 4:363-372.
7. Gupta V., Mychalczak B., Krug L. Hemithoracic radiation therapy after pleurectomy/decortications for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2005, 63:1045-1052.
8. Minatel E., Trovo M., Polesel J. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung. J Thorac Oncol 2012, 7:1862-1866.
9. Mackie T.R., Holmes T., Swerdloff S. Tomotherapy: a new concept for delivery of conformal radiotherapy. Med Phys 1993, 20:1709-1719.
10. Geurts M., Gonzalez J., Serrano-Ojeda P. Longitudinal study using a diode phantom for helical tomotherapy IMRT QA. Med Phys 2009, 36:4977-4983.
11. Weder W., Stahel R.A., Bernhard J. Swiss Group for Clinical Cancer Research. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007, 18:1196-1202.
12. Krug L.M., Pass H.I., Rusch V.W. Multicenter phase II trial of neo-adjuvant pemetrexed plus cisp0latin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009, 27:3007-3013.
13. Van Schil P.E., Baas P., Gaafar R. European Organization for Research and Treatment of Cancer (EORTC) Lung Cancer Group. Trimodality therapy for malignant pleural mesothelioma: results from a EORTC phase II multicentre trial. Eur Respir J 2010, 36:1362-1369.
14. Graham M.V., Purdy J.A., Emami B. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45:323-329.
15. Kwa S.L.S., Lebesque J.V., Theuws J.C.M. Radiation pneumonitis as a function of mean dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998, 42:1-9.
16. De Perrot M., Field R., Cho B.C. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 2009, 27:1413-1418.
17. Gomez D.R., Hong D.S., Allen P.K. Pattern of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thor Oncol 2013, 8:238-245.
18. Rosenzweig K.E., Zauderer M.G., Laser B. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2012, 83:1278-1283.